Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionDividends Paid - CommonDividends Paid - CommonExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares IssuedShares RepurchasedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

GE HealthCare Technologies (GEHC) Gains from Investment Securities (2022 - 2026)

GE HealthCare Technologies filings provide 5 years of Gains from Investment Securities readings, the most recent being $92.0 million for Q1 2026.

  • On a quarterly basis, Gains from Investment Securities rose 1.1% to $92.0 million in Q1 2026 year-over-year; TTM through Mar 2026 was $70.0 million, a 87.74% decrease, with the full-year FY2025 number at $69.0 million, down 85.95% from a year prior.
  • Gains from Investment Securities hit $92.0 million in Q1 2026 for GE HealthCare Technologies, up from -$284.0 million in the prior quarter.
  • In the past five years, Gains from Investment Securities ranged from a high of $464.0 million in Q4 2023 to a low of -$284.0 million in Q4 2025.
  • Median Gains from Investment Securities over the past 5 years was $13.0 million (2023), compared with a mean of $62.4 million.
  • Biggest five-year swings in Gains from Investment Securities: skyrocketed 3000.0% in 2023 and later tumbled 1615.38% in 2024.
  • GE HealthCare Technologies' Gains from Investment Securities stood at -$16.0 million in 2022, then skyrocketed by 3000.0% to $464.0 million in 2023, then fell by 13.58% to $401.0 million in 2024, then tumbled by 170.82% to -$284.0 million in 2025, then soared by 132.39% to $92.0 million in 2026.
  • The last three reported values for Gains from Investment Securities were $92.0 million (Q1 2026), -$284.0 million (Q4 2025), and $320.0 million (Q3 2025) per Business Quant data.